Procter & Gamble Health Q4 Results
- BSE: 500126
- NSE: PGHL
- ISIN: INE199A01012
- Sector: Biotechnology & Drugs
BSE
5,285.55
-12.70 (-0.24%)
-12.70 (-0.24%)Volume64.00
Updated: Thu 10 Oct, 2024 | 15:29:36
NSE
5,280.05-25.85 (-0.49%)
-25.85 (-0.49%)Volume2.37 K
Updated: Thu 10 Oct, 2024 | 15:29:37
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹283.88 Cr.(12.44%)
- Operating Profit₹20.90 Cr.(-65.51%)
- Profit After Tax₹16.78 Cr.(-63.96%)
- Operating Margin7.36%(-42.91%)
Note: Comparison is on YoY basis
Quarterly - Procter & Gamble Health Q4 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 23 | QoQ Comp | Jun 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 283.88 | 320.92 | -% | 301.18 | -% |
| Selling/ General/ Admin Expenses Total | 48.63 | 60.73 | -% | 55.40 | -% |
| Depreciation/ Amortization | 7.16 | 5.89 | -% | 6.50 | -% |
| Other Operating Expenses Total | 107.83 | 82.60 | -% | 106.69 | -% |
| Total Operating Expense | 262.98 | 247.15 | -% | 262.34 | -% |
| Operating Income | 20.90 | 73.77 | -% | 38.84 | -% |
| Net Income Before Taxes | 22.83 | 78.53 | -% | 44.13 | -% |
| Net Income | 16.78 | 59.19 | -% | 29.82 | -% |
| Diluted Normalized EPS | 19.05 | 34.73 | -% | 17.90 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Garuda Construction and Engineering Limited IPO: GMP, subscription status to review. Buy or not?
4 min read03:20 PM IST - Markets
02Buy or sell: Vaishali Parekh recommends three stocks to buy today — October 10
3 min read06:11 AM IST - Markets
03From ₹11 to ₹164: Penny stock turns multibagger, rises over 1,300% in 4 years
3 min read07:48 AM IST